Mycophenolate mofetil: A useful immunosuppressive in inflammatory eye disease

Ophthalmology

Volumn 106, Issue 2, 1999, Pages 370-374

  Larkin, Genevieve ^a,b   Lightman, Susan ^a  

^a MOORFIELDS EYE HOSPITAL   (United Kingdom)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; IMMUNOMODULATING AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; T LYMPHOCYTE ANTIBODY; TACROLIMUS;

ADULT; AGED; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; DRUG EFFICACY; DRUG INDUCED DISEASE; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; PRIORITY JOURNAL; SCLERITIS; TREATMENT OUTCOME; UVEITIS;

EID: 0033506431     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-6420(99)90078-7     Document Type: Article

References (21)

1. Rothova A, Suttorp-van Schulten MSA, FritsTreffers W, Kijlstra A. Causes and frequency of blindness in patients with intraocular inflammatory disease. Br J Ophthalmol 1996;80: 332-6.
2. Lightman S. New therapeutic options in uveitis. Eye 1997;11: 222-6.
3. Dick AD. Experimental approaches to specific immunotherapies in autoimmune disease: future treatment of endogenous posterior uveitis? Br J Ophthalmol 1995;79:81-8.
4. Weiner HL. Oral tolerance: immune mechanisms and treatment of autoimmune diseases. Immunol Today 1997;18:335-43.
5. Behrend M. A review of clinical experience with the novel immunosuppressive drug mycophenolate mofetil in renal transplantation. Clin Nephrol 1996;45:336-41.
6. Siconolfi L. Mycophenolate mofetil (CellCept): immunosuppression on the cutting edge. AACN Clin Issues 1996;7:390-402.
7. Spatz S, Rudnicka A, McDonald CJ. Mycophenolic acid in psoriasis. Br J Dermatol 1978;98:429-35.
8. Epinette WW, Parker CM, Jones EL, Greist MC. Mycophenolic acid for psoriasis. A review of pharmacology, long-term efficacy, and safety. J Am Acad Dermatol 1987;17: 962-71.
9. Böhm M, Beissert S, Schwarz T, et al. Bullous pemphigoid treated with mycophenolate mofetil. Lancet 1997;349:541.
10. Enk AH, Knop J. Treatment of pemphigus vulgaris with mycophenolate mofetil. Lancet 1997;350:494.
11. Goldblum R. Therapy of rheumatoid arthritis with mycophenolate mofetil. ClinExpRheumatol 1993:11(suppl 8):S117-9.
12. Zimmer-Molsberger B, Knauf W, Thiel E. Mycophenolate mofetil for severe autoimmune haemolytic anemia. Lancet 1997;350:1003-4.
13. Chanaud NP III, Vistica BP, Eugui E, et al. Inhibition of experimental autoimmune uveoretinitis by mycophenolate mofetil, an inhibitor of purine metabolism. Exp Eye Res 1995;61:429-34.
14. Allison AC, Eugui EM. Immunosuppressive and other effects of mycophenolic acid and an ester prodrug, mycophenolate mofetil. Immunol Rev 1993;136:5-28.
15. Lipsky JJ. Mycophenolate mofetil. Lancet 1996;348:1357-9.
16. Allison AC, Eugui EM. Mycophenolate mofetil (RS-61443): mode of action and effects on graft rejection. In: Thompson AW, Starzl TE, eds. Immunosuppressive Drugs: Developments in Anti-rejection Therapy. London; Boston: E. Arnold, 1994;141-59.
17. Young CJ, Sollinger HW, Mycophenolate mofetil (RS-61443). In: Kupiec-Weglinski JW, ed. New Immunosuppressive Modalities in Organ Transplantation. Austin, TX: RG Landes Company, 1994;1-17.
18. Allison AC, Kowalski WJ, Muller CJ, et al. Mycophenolic acid and brequinar, inhibitors of purine and pyrimidine synthesis, block the glycosylation of adhesion molecules. Transplant Proc 1993;25(suppl 2):67-70.
19. European Mycophenolate Mofetil Cooperative Study Group. Placebo-controlled study of mycophenolate mofetil combined with cyclosporine and corticosteroids for prevention of acute rejection. Lancet 1995;345:1321-5.
20. Sollinger HW, US Renal Transplant Mycophenolate Mofetil Study Group. Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. Transplantation 1995;60:225-32.
21. Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group. A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. Transplantation 1996;61:1029-37.